Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Use of probiotics in medical devices applied to some common pathologies.

Verrucci M, Iacobino A, Fattorini L, Marcoaldi R, Maggio A, Piccaro G.

Ann Ist Super Sanita. 2019 Oct-Dec;55(4):380-385. doi: 10.4415/ANN_19_04_12.

2.

Caveolin-1 Endows Order in Cholesterol-Rich Detergent Resistant Membranes.

Raggi C, Diociaiuti M, Caracciolo G, Fratini F, Fantozzi L, Piccaro G, Fecchi K, Pizzi E, Marano G, Ciaffoni F, Bravo E, Fiani ML, Sargiacomo M.

Biomolecules. 2019 Jul 17;9(7). pii: E287. doi: 10.3390/biom9070287.

3.

Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis Infection.

Riccomi A, Piccaro G, Christensen D, Palma C, Andersen P, Vendetti S.

Front Immunol. 2019 May 3;10:934. doi: 10.3389/fimmu.2019.00934. eCollection 2019.

4.

The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.

Iacobino A, Giannoni F, Pardini M, Piccaro G, Fattorini L.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00273-19. doi: 10.1128/AAC.00273-19. Print 2019 Jul.

5.

Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Int J Mycobacteriol. 2017 Jul-Sep;6(3):213-221. doi: 10.4103/ijmy.ijmy_85_17. Review.

6.

Activity of drugs against dormant Mycobacterium tuberculosis.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S94-S95. doi: 10.1016/j.ijmyco.2016.09.061. Epub 2016 Nov 12.

7.

Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02296-16. doi: 10.1128/AAC.02296-16. Print 2017 Mar.

8.

HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.

Cafaro A, Piccaro G, Altavilla G, Gigantino V, Matarese G, Olivieri E, Ferrantelli F, Ensoli B, Palma C.

BMC Infect Dis. 2016 Aug 22;16(1):442. doi: 10.1186/s12879-016-1724-7.

9.

Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation.

Iona E, Pardini M, Mustazzolu A, Piccaro G, Nisini R, Fattorini L, Giannoni F.

J Microbiol. 2016 Aug;54(8):565-72. doi: 10.1007/s12275-016-6150-4. Epub 2016 Aug 2.

PMID:
27480637
10.

Gender differences in pain and its relief.

Pieretti S, Di Giannuario A, Di Giovannandrea R, Marzoli F, Piccaro G, Minosi P, Aloisi AM.

Ann Ist Super Sanita. 2016 Apr-Jun;52(2):184-9. doi: 10.4415/ANN_16_02_09. Review.

11.

Tuberculosis in migrants from 106 countries to Italy, 2008-2014.

Fattorini L, Mustazzolu A, Borroni E, Piccaro G, Giannoni F, Cirillo DM; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group.

Eur Respir J. 2016 Apr;47(4):1273-6. doi: 10.1183/13993003.01844-2015. Epub 2016 Feb 4. No abstract available.

12.

Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis.

Piccaro G, Poce G, Biava M, Giannoni F, Fattorini L.

J Antibiot (Tokyo). 2015 Nov;68(11):711-4. doi: 10.1038/ja.2015.52. Epub 2015 May 6. No abstract available.

PMID:
25944535
13.

Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis.

Piccaro G, Pietraforte D, Giannoni F, Mustazzolu A, Fattorini L.

Antimicrob Agents Chemother. 2014 Dec;58(12):7527-33. doi: 10.1128/AAC.03169-14. Epub 2014 Oct 6.

14.

Gender-dependent resiliency to stressful and metabolic challenges following prenatal exposure to high-fat diet in the p66(Shc-/-) mouse.

Bellisario V, Berry A, Capoccia S, Raggi C, Panetta P, Branchi I, Piccaro G, Giorgio M, Pelicci PG, Cirulli F.

Front Behav Neurosci. 2014 Aug 22;8:285. doi: 10.3389/fnbeh.2014.00285. eCollection 2014.

15.

Targeting dormant bacilli to fight tuberculosis.

Fattorini L, Piccaro G, Mustazzolu A, Giannoni F.

Mediterr J Hematol Infect Dis. 2013 Nov 19;5(1):e2013072. doi: 10.4084/MJHID.2013.072. Review.

16.

Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.

Palma C, Schiavoni G, Abalsamo L, Mattei F, Piccaro G, Sanchez M, Fernandez C, Singh M, Gabriele L.

Eur J Immunol. 2013 Sep;43(9):2386-97. doi: 10.1002/eji.201243245. Epub 2013 Jul 15.

17.

Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.

Piccaro G, Giannoni F, Filippini P, Mustazzolu A, Fattorini L.

Antimicrob Agents Chemother. 2013 Mar;57(3):1428-33. doi: 10.1128/AAC.02154-12. Epub 2013 Jan 7.

18.

Drug-resistant tuberculosis among foreign-born persons in Italy.

Fattorini L, Mustazzolu A, Piccaro G, Pardini M, Filippini P, Giannoni F, Migliori GB, Sotgiu G, Borroni E, Cirillo DM; Italian Multicentre Study on Resistance to Antituberculosis Drugs Group.

Eur Respir J. 2012 Aug;40(2):497-500. No abstract available.

19.

Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy.

Fattorini L, Migliori GB, Cassone A, Mustazzolu A, Piccaro G, Filippini P, Cirillo DM, Borroni E; Italian Multicentre Study on Resistance to Antituberculosis Drugs Group.

Eur Respir J. 2012 May;39(5):1263-6. doi: 10.1183/09031936.00129011. No abstract available.

20.

Activity of drugs against dormant Mycobacterium tuberculosis.

Piccaro G, Filippini P, Giannoni F, Scipione L, Tortorella S, De Vita D, Mellini P, Fattorini L.

J Chemother. 2011 Jun;23(3):175-8. No abstract available.

PMID:
21742589
21.

The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.

Palma C, Spallek R, Piccaro G, Pardini M, Jonas F, Oehlmann W, Singh M, Cassone A.

Clin Dev Immunol. 2011;2011:690328. doi: 10.1155/2011/690328. Epub 2011 Mar 27.

22.

Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.

Fecchi K, Travaglione S, Spadaro F, Quattrini A, Parolini I, Piccaro G, Raggi C, Fabbri A, Felicetti F, Carè A, Fiorentini C, Sargiacomo M.

Int J Cancer. 2012 Mar 15;130(6):1273-83. doi: 10.1002/ijc.26092. Epub 2011 May 25.

23.

Activity of drug combinations against dormant Mycobacterium tuberculosis.

Filippini P, Iona E, Piccaro G, Peyron P, Neyrolles O, Fattorini L.

Antimicrob Agents Chemother. 2010 Jun;54(6):2712-5. doi: 10.1128/AAC.01736-09. Epub 2010 Mar 29.

Supplemental Content

Loading ...
Support Center